Abstract:ABSTRACT Naringenin is the central flavonoid in the biosynthesis of several bioactive compounds and presents a growing demand for its nutraceutical properties. Naringenin extraction from plants is non-viable due to low yields, and microbial platforms could represent a controlled and sustained alternative to produce it using several metabolic engineering tools. This study shows the naringenin production in Saccharomyces cerevisiae from glucose through a combined approach of systems biology, enzyme criteria selection, and a molecular engineering strategy. In silico prediction using a mixed integer linear programming (MILP) algorithm showed that the phenylpropanoid pathway was the shortest and most viable metabolic pathway. Two biscistronic constructs were generated using the PTV-1 2A peptide sequence, and a naringenin biofactory was assembled with the phenylalanine ammonia-lyase/tyrosine ammonia-lyase genes encoding phenylalanine/tyrosine ammonia-lyase ( Rhodobacter capsulatus ), 4-coumaroyl (4 Cl) encoding a p -coumaroyl-CoA ligase ( Solanum lycopersicum ), CHS encoding chalcone synthase ( Hypericum androsaemum ), and CHI encoding a chalcone isomerase ( Glycine max ). Naringenin productivity in batch fermentation was about 40.67 ± 3.47 μg/Lh with a 6.10 ± 0.52 mg/L titer (22.41 ± 1.91 μM) and a 3.26 ± 1.36 mg/g yield ( Y P / S ) with the detection of additional flavonoids. The obtained concentration is better than other related works in diverse engineered microorganisms. The results suggest a successful and optimizable alternative for the heterologous flavanone production in yeast combined with bicistronic expression mediated by a 2A peptide sequence for the first time. This strategy supports the production of extensive routes for other nutraceutical compounds. IMPORTANCE Flavonoids are a group of compounds generally produced by plants with proven biological activity, which have recently beeen recommended for the treatment and prevention of diseases and ailments with diverse causes. In this study, naringenin was produced in adequate amounts in yeast after in silico design. The four genes of the involved enzymes from several organisms (bacteria and plants) were multi-expressed in two vectors carrying each two genes linked by a short viral peptide sequence. The batch kinetic behavior of the product, substrate, and biomass was described at lab scale. The engineered strain might be used in a more affordable and viable bioprocess for industrial naringenin procurement.

Metabolic Engineering of Saccharomyces Cerevisiae for Production of 8-Dimenthylally Naringenin

Production of naringenin from D-xylose with co-culture of E. coli and S. cerevisiae

Metabolic Engineering of the Phenylpropanoid Pathway in Saccharomyces cerevisiae

Fermentation and Metabolic Pathway Optimization to De Novo Synthesize (2S)-Naringenin in Escherichia coli

Saccharomyces cerevisiae biofactory to produce naringenin using a systems biology approach and a bicistronic vector expression strategy in flavonoid production

Systematically Engineered Fatty Acid Catabolite Pathway for the Production of (2 S )-Naringenin in Saccharomyces cerevisiae

Metabolic engineering strategies for naringenin production enhancement in Streptomyces albidoflavus J1074

Enhanced Biosynthesis of Dihydromyricetin in Saccharomyces cerevisiae by Coexpression of Multiple Hydroxylases

Integrative metabolic engineering and cellular organelle engineering for improving biosynthesis of flavonoid compounds in saccharomyces cerevisiae

Biosynthesis and Engineering of Kaempferol in Saccharomyces Cerevisiae

Systems Metabolic Engineering of Saccharomyces cerevisiae for the High-Level Production of (2S)-Eriodictyol

Modular Optimization of Heterologous Pathways for De Novo Synthesis of (2S)-Naringenin in Escherichia coli

Fine-tuning of coumaric acid synthesis to increase naringenin production in yeast

Effects of metabolic pathway gene copy numbers on the biosynthesis of (2S)-naringenin in Saccharomyces cerevisiae

Metabolically engineering of Yarrowia lipolytica for the biosynthesis of naringenin from a mixture of glucose and xylose

Engineering Saccharomyces cerevisiae for the production of dihydroquercetin from naringenin

Improving (2S)-naringenin production by exploring native precursor pathways and screening higher-active chalcone synthases from plants rich in flavonoids

Metabolic engineering of Acinetobacter baylyi ADP1 for naringenin production

Optimizing the Biosynthesis of Dihydroquercetin from Naringenin in Saccharomyces cerevisiae

Efficient Biosynthesis of (2 S)-Eriodictyol from (2 S)-Naringenin in Saccharomyces cerevisiae through a Combination of Promoter Adjustment and Directed Evolution

Production of 8-Prenylnaringenin from Isoxanthohumol Through Biotransformation by Fungi Cells.